Sarah Meibusch

Five Aussie startups that raised $95.45 million this week

Weekly roundup detailing five Australian raises: Vaxxas' Series D plus debt facility amid executive changes, Skutopia's growth round, Send Payments' backing and CEO change, Apate.ai's seed, and Coursebox's seed.

Also Startup Daily·SmartCompany·Australian FinTech·Dealroom·Startup Daily

Vaccination biotech Vaxxas raises $49 million Series D, cuts C-suite amid broader layoffs

Australian biotech Vaxxas secured a Series D plus a debt facility while overhauling leadership: a new chair, founding CEO shifting to an advisory role, and CFO made redundant amid job cuts.

Also Business News Australia·SmartCompany·Cut Through Venture·Startup Daily·Startup Daily·SmartCompany·Startup Daily

Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology

Vaxxas announced a roughly A$90m financing — Series D equity led by SPRIM Global Investments plus debt — to advance its needle-free vaccine patch, alongside leadership changes including a new chair.

Ignition Lane's Great Big Wrap: VCs court cash, an M&A bash & Canva makes a splash

Ignition Lane's weekly tech roundup covering fresh Australian startup raises, new venture funds and closes, a wave of acquisitions, delistings and a liquidation, executive moves, and Canva's product launch.

Also Centerstone Capital portfolio·Startup Daily·SmartCompany·6clicks.com·ARN (ARNnet)·Centerstone Capital portfolio·Techboard·Startup Daily

KiRA Biotech appoints Global Pharma Business Leader as Independent Board Chair

Immunology Company Kira Biotech launches with $20M Series A Funding

Brisbane immunology company Kira Biotech has launched with a $20 million Series A, OneVentures leading alongside IP Group and Queensland government support, to progress its lead antibody KB312 into early human studies.